Nike, Inc., founded in 1964 and headquartered in Beaverton, Oregon, is a global leader in athletic footwear, apparel, and equipment. The company designs, develops, and markets a wide range of innovative products aimed at enhancing athletic performance and promoting an active lifestyle. Nike's brand portfolio includes iconic names such as Jordan, Converse, and the eponymous Nike brand, making it a crucial player in the global sportswear market.
| Bond Name | Country | Maturity | Coupon(%) | |
|---|---|---|---|---|
| NKE 2.38% 2026-11-01 USDNike, Inc. | United States | 2026-11-01 | 2.375 | 3.81 |
| NKE 2.40% 2025-03-27 USDNike, Inc. | United States | 2025-03-27 | 2.400 | 0.00 |
| NKE 2.75% 2027-03-27 USDNike, Inc. | United States | 2027-03-27 | 2.750 | 3.78 |
| NKE 2.85% 2030-03-27 USDNike, Inc. | United States | 2030-03-27 | 2.850 | 3.94 |
| NKE 3.25% 2040-03-27 USDNike, Inc. | United States | 2040-03-27 | 3.250 | 5.10 |
| NKE 3.38% 2046-11-01 USDNike, Inc. | United States | 2046-11-01 | 3.375 | 5.45 |
| NKE 3.38% 2050-03-27 USDNike, Inc. | United States | 2050-03-27 | 3.375 | 5.52 |
| NKE 3.63% 2043-05-01 USDNike, Inc. | United States | 2043-05-01 | 3.625 | 5.36 |
| NKE 3.88% 2045-11-01 USDNike, Inc. | United States | 2045-11-01 | 3.875 | 5.43 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Nike, Inc. began issuing bonds in 1995 to diversify its capital structure and support ongoing business needs, with notable issuances including a $1 billion bond in 2016 to refinance existing debt. The company’s bonds generally feature investment-grade ratings, reflecting its strong financial position. Current yields are competitive within the industry, often aligned with similar corporate bonds despite being slightly lower than the average yields for the consumer discretionary sector. Recently, Nike raised $2.5 billion in a multi-tranche offering that attracted significant investor interest due to favorable market conditions and the company's robust recovery post-pandemic.